Why MoCA Scores Are Not the Whole Story

A normal MoCA score doesn't rule out cognitive decline, and an abnormal score isn't a diagnosis—here's why the test's limitations matter.

The Montreal Cognitive Assessment (MoCA) is one of the most widely used screening tools for cognitive impairment and dementia, but a normal MoCA score does not guarantee that a person’s cognitive function is healthy, nor does an abnormal score confirm a diagnosis of dementia. The test is a brief, 10-minute screening instrument designed to detect mild cognitive impairment and early Alzheimer’s disease, but it captures only a narrow slice of cognitive function and can miss real impairment in some patients while incorrectly raising red flags in others. A 65-year-old retired accountant with early frontotemporal dementia might score perfectly on the MoCA while losing the ability to manage her finances and social relationships—domains the test doesn’t measure.

The MoCA has significant limitations that clinicians and patients need to understand. It was not designed to diagnose dementia, nor was it intended to be used as a standalone assessment. Instead, it is a single tool within a much larger diagnostic picture that includes a patient’s medical history, neuroimaging, laboratory work, functional decline, and sometimes additional cognitive testing. Over-relying on MoCA scores—either dismissing real cognitive concerns because the score is “normal” or assuming someone has dementia solely based on a low score—can lead to missed diagnoses, unnecessary worry, and delayed access to interventions that could help.

Table of Contents

What Does the MoCA Actually Measure?

The MoCA tests specific cognitive domains: attention, concentration, executive function, memory, language, visuospatial skills, and orientation. It does this very efficiently in about 10 minutes, making it practical for busy clinical settings. However, what it does not measure is equally important. The test does not assess complex executive function, reasoning across multiple steps, social cognition, emotional insight, or functional abilities—whether someone can actually manage medications, balance a checkbook, cook a meal, or live independently.

A person with semantic dementia, a variant that primarily affects language and semantic knowledge while leaving episodic memory and attention relatively intact, might score surprisingly well on the MoCA because the test emphasizes attention, naming, and visuospatial skills, even as they lose the ability to understand words and recognize familiar objects. The MoCA’s design also means it is sensitive to certain types of impairment while potentially missing others. It performs reasonably well at detecting early Alzheimer’s disease because Alzheimer’s affects memory, attention, and executive function—domains the MoCA probes. But patients with early cognitive decline from other causes—such as Lewy body dementia, primary progressive aphasia, or behavioral-variant frontotemporal dementia—may score near-normal on the MoCA while experiencing profound functional decline. A 70-year-old man with primary progressive aphasia may score a 24/30 on the MoCA because his attention and visuospatial skills remain intact, yet he may be unable to hold a conversation or read a menu—severe language impairment not adequately captured by the test’s limited language items.

Why MoCA Scores Can Miss Real Cognitive Decline

The sensitivity and specificity of the MoCA vary significantly depending on the population being tested and the cutoff score used. In research populations, the MoCA’s sensitivity for mild cognitive impairment ranges from 60% to 90%, depending on the study design—meaning it can miss 10% to 40% of people who actually have cognitive impairment. In community screening settings, where people volunteer or are randomly selected, sensitivity can be even lower because the tested population is less likely to actually have cognitive problems, and the prevalence of disease affects how well any test performs. One critical limitation is that the MoCA was validated primarily in English-speaking North American populations and on relatively small sample sizes. Translating and adapting the test across languages and cultures introduces additional variability. A recent immigrant with cognitive reserve built through multilingual education may score lower on the English-language MoCA due to language unfamiliarity, not cognitive decline.

Education level itself affects scores significantly—the test includes a correction for individuals with 12 years or fewer of education (adding 1 point to the total), but this correction does not fully account for how education influences cognitive performance. Someone with 18 years of education will naturally score higher than someone with 8 years of education, even if they have the same degree of cognitive decline. Additionally, the MoCA does not account for the rate of decline. A patient whose MoCA score remained stable at 24/30 for three years has a very different clinical picture than someone who declined from 29/30 to 24/30 in the same timeframe. The single MoCA score is a snapshot, and without longitudinal data, clinicians can miss important patterns. This is why many guidelines recommend repeat testing over time rather than relying on a single assessment.

MoCA Sensitivity by Clinical PopulationAlzheimer’s Disease85%Mild Cognitive Impairment75%Lewy Body Dementia62%Healthy Controls92%Frontotemporal Dementia58%Source: Cumulative data from multiple validation studies; sensitivity varies by population and cutoff score used

How Age and Education Complicate Interpretation

Age and education profoundly affect MoCA performance, yet these factors cannot be perfectly corrected by adding or subtracting points. The test was originally validated on people averaging around 73 years old, and performance naturally declines with advancing age even in cognitively healthy individuals. A 90-year-old with no cognitive disease may score 23/30, while a 60-year-old with no disease typically scores 27/30 or higher. There is no formal age-adjustment built into the standard MoCA scoring, which means clinicians must interpret scores within the context of age norms—knowledge that is not always readily available or consistently applied.

Education level has an even stronger effect. Someone with a graduate degree, built-in cognitive reserve, and a lifetime of mental stimulation may score 28/30 at age 85 with mild Alzheimer’s disease, while someone with a high school education and moderate decline might score 20/30 at the same age. The education correction of +1 point for those with ≤12 years of education is a rough adjustment that acknowledges this bias but does not fully resolve it. This means that using the same cutoff score (typically 26/30 as the threshold for normal) across all education and age groups will both overdiagnose cognitive impairment in less-educated, older individuals and potentially underdiagnose it in highly-educated, younger adults.

When MoCA Scores Are Normal but Decline Is Real

One of the most clinically important limitations is that patients can experience meaningful cognitive decline—noticeable to themselves and their families—while remaining above the “normal” MoCA cutoff. A 72-year-old physician who scored 28/30 on a MoCA administered during her annual physical still struggled to organize her medical records as well as she used to, occasionally forgot patient names she had known for years, and noticed she was slower at reading medical literature. Her family did not think she had dementia, and her MoCA was in the normal range, yet her cognitive changes were real and represented decline from her baseline. This scenario is common because the MoCA’s cutoff of 26/30 (or 27/30 in some guidelines) was designed to identify people with dementia or moderate cognitive impairment, not to detect subtle, early decline in people who were previously high-functioning.

This gap is particularly important in the era of amyloid-lowering therapies and early intervention. If cognitive decline is only recognized once someone scores below the MoCA threshold, the opportunity to intervene early—during the preclinical or prodromal stage—is lost. Some patients want to know if they are declining early so they can make life decisions, plan ahead, and explore interventions. For these individuals, a “normal” MoCA may provide false reassurance.

The Danger of False Positives and Over-Diagnosis

Just as the MoCA can miss real decline, it can also over-identify people as having cognitive impairment when they do not. Delirium, depression, anxiety, sleep deprivation, hearing loss, medication side effects, and pain all impair performance on the MoCA. A 78-year-old recovering from hip surgery, in pain, on opioid medication, and sleep-deprived in a hospital setting may score 22/30 on the MoCA—below the normal cutoff—yet have no underlying cognitive disease. Once he recovers from surgery, pain resolves, and medications are adjusted, his MoCA score may improve to 27/30.

Administering a single MoCA during acute illness can lead to a false diagnosis of dementia or mild cognitive impairment. Depression is a particularly important confounder. Older adults with major depressive disorder often score lower on cognitive screening tests due to reduced attention, processing speed, and motivation—phenomena collectively called “pseudo-dementia” or, more accurately, depression-related cognitive impairment. A depressed patient with a low MoCA score may be referred for dementia workup when what they actually need is treatment for depression. Furthermore, the MoCA does not measure mood or screen for depression, so clinicians relying solely on the MoCA might miss the actual problem.

MoCA Alone Does Not Diagnose Dementia

The most critical limitation is fundamentally about scope: the MoCA is a cognitive screening tool, not a diagnostic instrument. Dementia is defined not by a low score on a single test but by the presence of cognitive decline from baseline in one or more domains that interferes with the ability to function independently.

Diagnosing dementia requires a history of decline, assessment of functional impairment, medical evaluation to rule out reversible causes, sometimes neuroimaging to assess for stroke or atrophy, and sometimes additional testing such as neuropsychological evaluation, cerebrospinal fluid biomarkers, or positron emission tomography (PET) imaging. A low MoCA score is a red flag that warrants further workup, not a diagnosis. Conversely, a normal MoCA score in the presence of objective functional decline and a credible history of decline is not reassuring and should prompt additional evaluation.

The Importance of Longitudinal Data and Clinical Context

The most useful way to interpret MoCA scores is to view them as part of a series over time, combined with clinical history and functional assessment. A patient whose MoCA declined from 28/30 two years ago to 24/30 today has demonstrated cognitive decline even though both scores might be considered “low normal” or borderline depending on age and education. This decline over time is clinically meaningful and warrants investigation and possible intervention.

Similarly, a patient with an “abnormal” MoCA score who functions perfectly independently, has no history of decline, and whose family reports no cognitive concerns may not have clinically meaningful cognitive impairment—especially if depression, delirium, or other reversible causes have not been fully evaluated. The MoCA is best used as one piece of a comprehensive evaluation that includes careful history taking, assessment of functional abilities, medical and psychiatric evaluation, and imaging when indicated. It is a useful tool, but treating it as a standalone diagnostic test—or dismissing genuine cognitive concerns because an MoCA score is normal—misses the complexity of cognitive assessment and risks both over-diagnosis and under-diagnosis.

Frequently Asked Questions

If my MoCA score is normal, can I stop worrying about my memory?

Not necessarily. A normal MoCA score is reassuring but does not guarantee that you don’t have subtle cognitive decline, especially if you or your family have noticed actual changes in your ability to function. A single normal score should not override concerns about real decline in complex, high-level cognitive abilities.

What’s the difference between a low MoCA score and a dementia diagnosis?

A low MoCA score is a screening result that suggests the need for further evaluation. Dementia is a clinical diagnosis that requires evidence of cognitive decline from baseline, functional impairment in daily activities, and ruling out other causes. The diagnosis is made by a clinician considering multiple sources of information, not by a test score alone.

Why does my MoCA score sometimes vary when I take it multiple times?

Variation can occur due to sleep, mood, stress, pain, medications, anxiety about testing, or simply the random variability inherent in any test. Practice effects (improvement from taking the test before) can also affect scores. This is one reason why a single MoCA score should be interpreted cautiously and ideally compared to previous scores.

Does education affect my MoCA score?

Yes, significantly. Highly educated individuals typically score higher on the MoCA than less-educated individuals, regardless of cognitive health. The test adds 1 point for people with 12 or fewer years of education, but this adjustment does not fully account for education’s effects on test performance.

Should my doctor order brain imaging if my MoCA score is low?

Not automatically. Whether imaging is warranted depends on the clinical context—your history, other symptoms, functional decline, and whether there are red flags suggesting stroke, bleeding, or other structural brain disease. Your doctor should discuss this with you rather than ordering imaging based purely on MoCA results.


You Might Also Like